HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lun Xiao Selected Research
Lun Xiao Research Topics
Disease
3
Obesity
01/2022 - 01/2020
2
Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2022 - 01/2020
2
Venous Thrombosis (Deep-Vein Thrombosis)
10/2020 - 12/2019
2
Myeloid Leukemia (Leukemia, Myelocytic)
05/2017 - 12/2016
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1
Dyslipidemias (Dyslipidemia)
01/2022
1
Gestational Weight Gain
01/2022
1
Type 2 Diabetes Mellitus (MODY)
01/2022
1
Insulin Resistance
01/2022
1
Abdominal Aortic Aneurysm
11/2021
1
COVID-19
01/2021
1
Thrombosis (Thrombus)
10/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Kidney Diseases (Kidney Disease)
01/2020
1
Wilms Tumor (Wilm's Tumor)
12/2018
1
Leukemia
05/2017
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2016
1
Neoplasms (Cancer)
11/2015
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2015
1
Philadelphia Chromosome
11/2015
Drug/Important Bio-Agent (IBA)
2
Triglycerides (Triacylglycerol)
IBA
01/2022 - 01/2020
2
MicroRNAs (MicroRNA)
IBA
12/2019 - 11/2015
2
Proteins (Proteins, Gene)
FDA Link
12/2018 - 11/2015
1
Glycolipids
IBA
01/2022
1
Insulin (Novolin)
FDA Link
01/2022
1
HDL Lipoproteins
IBA
01/2022
1
Circular RNA
IBA
11/2021
1
Nucleic Acids
IBA
01/2021
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
10/2020
1
Long Noncoding RNA
IBA
10/2020
1
erucylphosphocholine
IBA
10/2020
1
LDL Cholesterol
IBA
01/2020
1
Transaminases (Aminotransferases)
IBA
01/2020
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2020
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2020
1
Blood Glucose (Blood Sugar)
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
12/2018
1
Povidone (Crospovidone)
IBA
05/2017
1
X-linked zinc finger protein
IBA
12/2016
1
pullulan
IBA
11/2015
1
Imatinib Mesylate (Gleevec)
FDA Link
11/2015
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
11/2015